Morishita Jintan Co., Ltd. (TYO:4524)
Japan
· Delayed Price · Currency is JPY 2,091.00
+6.00 (0.29%)
May 23, 2025, 3:30 PM JST
Morishita Jintan Revenue
In the fiscal year ending March 31, 2025, Morishita Jintan had annual revenue of 12.77B JPY with 2.90% growth. Morishita Jintan had revenue of 3.17B in the quarter ending March 31, 2025, with 4.17% growth.
Revenue
12.77B
Revenue Growth
+2.90%
P/S Ratio
0.67
Revenue / Employee
36.06M
Employees
354
Market Cap
8.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.77B | 360.00M | 2.90% |
| Mar 31, 2024 | 12.41B | 1.05B | 9.22% |
| Mar 31, 2023 | 11.36B | 1.80B | 18.78% |
| Mar 31, 2022 | 9.56B | 134.00M | 1.42% |
| Mar 31, 2021 | 9.43B | -345.00M | -3.53% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |